#50MILLIONSTEPS for Epilepsy: Angelini Pharma joins the challenge promoted by IBE and counts steps
The company has decided to join the #50MillionSteps campaign, inviting its employees to participate, with the goal of reaching 1 million steps.
Empowerment
-
-
New Headway report: environmental crisis has a major impact on mental health.
The result of 2022 report presented in Brussels at European Parliament
-
Headway - A new roadmap in Mental Health. Live from European Parliament
New report on Mental Health presented on September 28th
-
Headway - Focus Epilepsy. 2022 REPORT, RESULTS AND PERSPECTIVES
Among neurological disorders, Epilepsy is the 4th most common in Europe, causing 1.3 million DALYs (Disability Adjusted Life Years), and 941,000 YLDs (Years of Life Lost -YLLs).
-
Angelini Pharma's commitment in Brain Health
Brain health is a global health priority with mental health and neurological disorders added to the list of priority non-communicable diseases by leading health organizations and experts.
-
Angelini Pharma presents Lampi (Lightnings), an auteur short film on brain health
Lampi (Lightnings) is a short film by Italian director Paolo Santamaria. It is aimed at raising awareness about brain health and the stigma surrounding patients
-
-
What if your parents were sad not only because they're getting older?
A disease awareness campaign promoted by Angelini Pharma
